Recruiting studies: Moderate To Severe Glabellar Lines

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between
Phase 3 · 23 location(s) · Ipsen · NCT07427797 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · 60 location(s) · Ipsen · NCT07435428 Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar
Phase 3 · 15 location(s) · JHM BioPharma (Tonghua) Co. , Ltd. · NCT06937944 To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)
Phase 3 · 1 location(s) · Huons Biopharma · NCT06205797

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.